Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group

Systemic immunoglobulin light chain (AL) amyloidosis is a heterogeneous rare disease driven by a destructive monoclonal gammopathy and typified by misfolded immunoglobulin light and/or heavy chains which aggregate and deposit in organs as insoluble amyloid fibrils. Disease heterogeneity is driven by...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauermann, Michelle L., Clarke, John O., Litchy, William J., Obici, Laura, Lousada, Isabelle, Gertz, Morie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567953/
https://www.ncbi.nlm.nih.gov/pubmed/37658177
http://dx.doi.org/10.1007/s12325-023-02637-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567953/
https://www.ncbi.nlm.nih.gov/pubmed/37658177
http://dx.doi.org/10.1007/s12325-023-02637-4

Ejemplares similares